CIS Medical Device Symposium Addresses Requirements of Federal Sunshine Act Regulations and Discusses Ongoing State Compliance and Reporting Requirements
Upcoming symposium is designed specifically for medical device companies interested in learning critical strategies to better manage federal and state compliance and reporting requirements.
- Los Angeles-Long Beach, CA (1888PressRelease) March 26, 2013 - Compliance Implementation Services (CIS), a leading life sciences consulting firm, presents the breakfast symposium, "Sunshine - How to Weather the Storm of Federal and State Regulations: What Every Medical Device Company Should Know," featuring industry experts from CIS and Advanced Orthopaedic Solutions (AOS). The panel will discuss the key Sunshine Act regulations and lead attendees through a practical application that aligns with Federal and State Compliance and Reporting requirements.
"We've entered a new era of non-compliance enforcement as regulators shift attention from pharmaceutical manufacturers and step up investigations and settlements with medical device and diagnostics companies. With the increased risk of individual liability as well as corporate liability, companies must improve compliance processes and strategies to meet the new standards of an effective corporate compliance program," said Peter Lee, Practice Lead, West Coast Compliance & Ethics and Program Chairman.
Paramount to the compliance program is adherence to "The Physician Payment Sunshine Act," which requires applicable manufacturers of drugs, devices, biologicals, or medical supplies to report annually certain payments or
transfers of value provided to physicians or teaching hospitals ("covered recipients"). The purpose of this law is to provide patients with transparency into the relationships between healthcare providers and life science manufacturers.
By attending this breakfast, attendees will learn key insights and best practices from medical device companies who have successfully implemented the Federal and State compliance and reporting requirements. Program topics include:
- Federal and State Workshop - Key Sunshine Act elements and practical application
- Ensuring Compliance, Minimizing Impact - Aligning your compliance program to the reporting requirements and the impact of exposure on your program
- AOS's Journey to Compliance - A medical device company's perspective on compliance requirements including a timeline on when to engage experts and resources
- Panelist Roundtable - The medical device selling model and the challenges of meeting the regulations based on that model
The symposium is hosted by CIS' Commercial Compliance Practice and will be held on March 26, 2013 from 8:00-10:30am PST at the Renaissance Long Beach Hotel. Registration is open to life science companies by contacting events ( @ ) cis-partners dot com dot Space is limited dot
About Compliance Implementation Services (CIS) Compliance Implementation Services (CIS) is a consulting firm focused on helping life sciences clients proactively manage complex compliance requirements. We offer a broad portfolio of services and solutions that expand deep into the clinical, manufacturing and commercial disciplines and that align with our clients' strategic priorities and business operations. CIS continually provides leadership, global regulatory knowledge, industry experience and a problem-solving culture that responds to today's compliance and commercial challenges. For more information, visit www.cis-partners.com
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam